Identification of the Best Treatment Pathway for Patients With Relapsed/Refractory Lymphocytic B-derived Non-Hodgkin Lymphoma
Clinical trial NCT07614035 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07614035
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-30
- Primary completion
- 2028-12-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.